Publications by authors named "Shinji Takeuchi"

Claim this Profile
E
Efficacy and Safety of Olomorasib in Combination with Pembrolizumab in Treatment of Patients with KRAS G12C-Mutant Advanced NSCLC.
Timothy F Burns, Natraj Reddy Ammakkanavar, Antoine Hollebecque, Dae Ho Lee, Takafumi Koyama, Shinji Takeuchi

J Thorac Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung Cancer.
Koji Fukuda, Shigeki Nanjo, Shinji Takeuchi, Turja Chakrabarti, Tyiesha Brown

J Thorac Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Additional Immunosuppressive Drugs for Corticosteroid-refractory Immune Checkpoint Inhibitor-induced Myocarditis: Two Case Reports.
Hiroyuki Sakaguchi, Shigeki Nanjo, Shigeki Sato, Hiroshi Kotani, Akihiro Nishiyama, Shinji Takeuchi

Intern Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Medullary carcinoma of the pancreas with promoter hypermethylation, induced deficient mismatch repair, successfully treated with an immune checkpoint inhibitor.
Koushiro Ohtsubo, Shigeki Sato, Hiroyuki Sakaguchi, Hiroshi Kotani, Akihiro Nishiyama, Shinji Takeuchi

Front Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive genomic profiling for advanced hepatocellular carcinoma in clinical practice.
Takeshi Terashima, Tatsuya Yamashita, Kuniaki Arai, Noboru Takata, Tomoyuki Hayashi, Shinji Takeuchi

Hepatol Int· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab efficacy in a tumor mutation burden-high glioblastoma patient: A case study and implications for precision oncology.
Akihiro Nishiyama, Shigeki Sato, Hiroyuki Sakaguchi, Hiroshi Kotani, Kaname Yamashita, Shinji Takeuchi

Cancer Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Methylation of Tumor-suppressive miRNAs and Mutations in Pancreatic Juice.
Koushiro Ohtsubo, Kunio Miyake, Shigeki Sato, Hiroyuki Sakaguchi, Koji Fukuda, Shinji Takeuchi

Anticancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Supramolecular Biosensor for Rapid and High-Throughput Quantification of a Disease-Associated Niacin Metabolite.
Masaya Ueno, Hiroki Sugiyama, Feng Li, Tatsuya Nishimura, Hiroshi Arakawa, Shinji Takeuchi

Anal Chem· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive antitumor immune response boosted by dual inhibition of SUMOylation and MEK in MYC-expressing KRAS-mutant cancers.
Hiroshi Kotani, Tomoyoshi Yamano, Justin C Boucher, Shigeki Sato, Hiroyuki Sakaguchi, Shinji Takeuchi

Exp Hematol Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damage.
Hiroshi Kotani, Hiroko Oshima, Justin C Boucher, Tomoyoshi Yamano, Hiroyuki Sakaguchi, Shinji Takeuchi

J Biomed Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in the treatment of K601E-mutated lung carcinoma: a case report of rapid response and resistance to dabrafenib and trametinib.
Akihiro Nishiyama, Shigeki Sato, Hiroyuki Sakaguchi, Hiroshi Kotani, Kaname Yamashita, Shinji Takeuchi

Front Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAF-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program.
Daisuke Kotani, Atsuo Takashima, Takeshi Kato, Taroh Satoh, Toshiki Masuishi, Shinji Takeuchi

Clin Colorectal Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting WEE1 enhances the antitumor effect of KRAS-mutated non-small cell lung cancer harboring TP53 mutations.
Koji Fukuda, Shinji Takeuchi, Sachiko Arai, Shigeki Nanjo, Shigeki Sato

Cell Rep Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Navigating treatment pathways for cardiac intimal sarcoma with N666K mutation.
Akihiro Nishiyama, Shigeki Sato, Hiroyuki Sakaguchi, Hiroshi Kotani, Kaname Yamashita, Shinji Takeuchi

Front Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful second-line treatment with cabozantinib for hepatocellular carcinoma harboring cytoplasmic mesenchymal-epithelial transition factor amplification.
Makoto Yamamoto, Takeshi Terashima, Tatsuya Yamashita, Akihiro Seki, Hidetoshi Nakagawa, Shinji Takeuchi

Hepatol Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of ultrafast camera-based single fluorescent-molecule imaging for cell biology.
Takahiro K Fujiwara, Shinji Takeuchi, Ziya Kalay, Yosuke Nagai, Taka A Tsunoyama

J Cell Biol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrafast single-molecule imaging reveals focal adhesion nano-architecture and molecular dynamics.
Takahiro K Fujiwara, Taka A Tsunoyama, Shinji Takeuchi, Ziya Kalay, Yosuke Nagai

J Cell Biol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FIGHT-102: A phase 1 study of pemigatinib in Japanese patients with advanced malignancies.
Yutaka Fujiwara, Yasutoshi Kuboki, Masayuki Furukawa, Nobumasa Mizuno, Hiroki Hara, Shinji Takeuchi

Cancer Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MET kinase inhibitor reverses resistance to entrectinib induced by hepatocyte growth factor in tumors with NTRK1 or ROS1 rearrangements.
Yohei Takumi, Sachiko Arai, Chiaki Suzuki, Koji Fukuda, Akihiro Nishiyama, Shinji Takeuchi

Cancer Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of EGFR and MEK surmounts entrectinib resistance in a brain metastasis model of NTRK1-rearranged tumor cells.
Chiaki Suzuki, Akihiro Nishiyama, Sachiko Arai, Shoichiro Tange, Atsushi Tajima, Shinji Takeuchi

Cancer Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Skin Toxicity Caused by Sequential Anti-PD-1 Antibody and Alectinib in Non-small-cell Lung Cancer: A Report of Two Cases and a Literature Review.
Akihiro Nishiyama, Yoshihiro Hattori, Shinji Takeuchi, Azusa Tanimoto, Miyako Satouchi

Intern Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylation of Tumor Suppressive miRNAs in Plasma from Patients With Pancreaticobiliary Diseases.
Koushiro Ohtsubo, Kunio Miyake, Sachiko Arai, Koji Fukuda, Chiaki Suzuki, Shinji Takeuchi

Cancer Diagn Progn· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT3 inhibition suppresses adaptive survival of ALK-rearranged lung cancer cells through transcriptional modulation of apoptosis.
Naohiro Yanagimura, Shinji Takeuchi, Koji Fukuda, Sachiko Arai, Azusa Tanimoto

NPJ Precis Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analytical survey of benzotriazole UV stabilizers in plastic products and their endocrine-disrupting potential via human estrogen and androgen receptors.
Yuuta Sakuragi, Hideshige Takada, Hiroya Sato, Atsuhito Kubota, Masaru Terasaki, Shinji Takeuchi

Sci Total Environ· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer.
Hiroyuki Yasuda, Eiki Ichihara, Jun Sakakibara-Konishi, Yoshitaka Zenke, Shinji Takeuchi

Lung Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis